Eli Lilly and Co Q3 2020 Earnings Call Summary - Thomson StreetEvents

Eli Lilly and Co Q3 2020 Earnings Call Summary

Eli Lilly and Co Q3 2020 Earnings Call Summary - Thomson StreetEvents
Eli Lilly and Co Q3 2020 Earnings Call Summary
Published Oct 27, 2020
24 pages (13527 words) — Published Oct 27, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of LLY.N earnings conference call or presentation 27-Oct-20 1:00pm GMT

  
Brief Excerpt:

...A. Note: Will focus on non-GAAP financial measures, excluding financial contribution from Elanco during 2019, and present EPS as though full disposition via exchange offer was complete on 01/01/19. 1....

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Eli Lilly and Co
Ticker
LLY.N
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Gregory B. Gilbert - Truist Securities, Inc., Research Division - Analyst : I'm going to start with another one on Alzheimer's. Dan, I'm not sure to what degree you can comment on this, but I'm curious how interrelated your studies are and the agency's view of aducanumab. Maybe asked another way, do you think the agency can act on their application without seeing your data, which is coming pretty soon? It seems to me that what you're bringing to the table is pretty important in the field. And then secondly, I know it's a little early. I was hoping you could talk to your growing confidence in the IL-2 approach since you signed that collaboration a few years ago. It looks like there's some additional data coming at ACR as well.

Table Of Contents

Eli Lilly and Co to Provide an Overview of Tirzepatide Phase 3 Clinical Program - Conference Call Summary – 2020-11-20 – US$ 54.00 – Edited Brief of LLY.N conference call or presentation 20-Nov-20 4:00pm GMT

Eli Lilly and Co to Provide an Overview of Tirzepatide Phase 3 Clinical Program - Conference Call Transcript – 2020-11-20 – US$ 54.00 – Edited Transcript of LLY.N conference call or presentation 20-Nov-20 4:00pm GMT

Eli Lilly and Co at Wolfe Research Healthcare Conference (Virtual) Transcript – 2020-11-18 – US$ 54.00 – Edited Transcript of LLY.N presentation 18-Nov-20 6:30pm GMT

Eli Lilly and Co at Sanford C Bernstein Operational Decisions Conference (Virtual) Transcript – 2020-11-16 – US$ 54.00 – Edited Transcript of LLY.N presentation 16-Nov-20 4:00pm GMT

Eli Lilly and Co Q3 2020 Earnings Call Transcript – 2020-10-27 – US$ 54.00 – Edited Transcript of LLY.N earnings conference call or presentation 27-Oct-20 1:00pm GMT

Eli Lilly and Co at HMG Live Houston CIO Executive Leadership Summit Transcript – 2020-10-20 – US$ 54.00 – Edited Transcript of LLY.N presentation 20-Oct-20 5:10pm GMT

Eli Lilly and Co to Provide Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs - Conference Call Summary – 2020-10-07 – US$ 54.00 – Edited Brief of LLY.N conference call or presentation 7-Oct-20 4:00pm GMT

Eli Lilly and Co to Provide Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs - Conference Call Transcript – 2020-10-07 – US$ 54.00 – Edited Transcript of LLY.N conference call or presentation 7-Oct-20 4:00pm GMT

Eli Lilly and Co to Discuss ESMO 2020 Presentations - Conference Call Transcript – 2020-09-21 – US$ 54.00 – Edited Transcript of LLY.N conference call or presentation 21-Sep-20 7:00pm GMT

Eli Lilly and Co at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript – 2020-09-17 – US$ 54.00 – Edited Transcript of LLY.N presentation 17-Sep-20 12:40pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Eli Lilly and Co Q3 2020 Earnings Call Summary" Oct 27, 2020. Alacra Store. May 15, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2020-Eli-Lilly-and-Co-Earnings-Call-B12867062>
  
APA:
Thomson StreetEvents. (2020). Eli Lilly and Co Q3 2020 Earnings Call Summary Oct 27, 2020. New York, NY: Alacra Store. Retrieved May 15, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2020-Eli-Lilly-and-Co-Earnings-Call-B12867062>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.